A randomized controlled longitudinal naturalistic trial testing the effects of automatic self transcending meditation on heart rate variability in late life depression: study protocol

详细信息    查看全文

• 作者：Zareen Amtul (1)
  Amanda Arena (1)
  Hussein Hirjee (2)
  Zaineb U Khan (1)
  Pramudith M Maldeniya (1)
  Ronnie I Newman (3)
  Amer M Burhan (1)
  Stephen Wetmore (4)
  Akshya Vasudev (1) (5) (6)
  
  1. Division of Geriatric Psychiatry ; Department of Psychiatry ; Western University ; London ; N6A 5 W9 ; ON ; Canada
  2. Schulich School of Medicine and Dentistry ; Western University ; London ; N6A 5C1 ; ON ; Canada
  3. Department of Research and Health Promotion ; The Art of Living Foundation ; San Francisco ; CA ; USA
  4. Department of Family Medicine ; Western University ; London Health Sciences Centre ; London ; N6A 5C1 ; ON ; Canada
  5. Division of Clinical Pharmacology ; Department of Medicine ; Western University ; London ; N6A 1H4 ; ON ; Canada
  6. A2-607 ; Victoria Hospital ; London Health Sciences Centre ; 800 Commissioners Road East ; London ; N6A 5 W9 ; ON ; Canada
  
• 关键词：Cardiovascular autonomic testing ; Automatic self transcending meditation ; Late life depression ; Heart rate variability
• 刊名：BMC Complementary and Alternative Medicine
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：14
• 期：1
• 全文大小：460 KB
• 参考文献：1. Steffens, DC, Skoog, I, Norton, MC, Hart, AD, Tschanz, JT, Plassman, BL, Wyse, BW, Welsh-Bohmer, KA, Breitner, JC (2000) Prevalence of depression and its treatment in an elderly population: the Cache County study. Arch Gen Psychiatry 57: pp. 601-607 CrossRef
  2. Alexopoulos, GS (2005) Depression in the elderly. Lancet 365: pp. 1961-1970 CrossRef
  3. Stahl, SM, Grady, MM (2003) Differences in mechanism of action between current and future antidepressants. J Clin Psychiatry 64: pp. 13-17
  4. Vasudev, A, O鈥橞rien, JT, Tan, MP, Parry, SW, Thomas, AJ (2011) A study of orthostatic hypotension, heart rate variability and baroreflex sensitivity in late-life depression. J Affect Disord 131: pp. 374-378 CrossRef
  5. Gorman, JM, Sloan, RP (2000) Heart rate variability in depressive and anxiety disorders2. Am Heart J 140: pp. 77-83 CrossRef
  6. Roth, R (1994) Maharishi Mahesh Yogi鈥檚 Transcendental Meditation. Primus, Washington DC
  7. Trivedi, MH, Rush, AJ, Wisniewski, SR, Nierenberg, AA, Warden, D, Ritz, L, Norquist, G, Howland, RH, Lebowitz, B, McGrath, PJ, Shores-Wilson, K, Biggs, MM, Balasubramani, GK, Fava, M (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163: pp. 28-40 CrossRef
  8. Kelly, K, Posternak, M, Alpert, JE (2008) Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues Clin Neurosci 10: pp. 409-418
  9. Purohit, MP, Wells, RE, Zafonte, R, Davis, RB, Yeh, GY, Phillips, RS (2013) Neuropsychiatric symptoms and the use of mind-body therapies. J Clin Psychiatry 74: pp. e520-e526 CrossRef
  10. Toane, EB (1976) The transcendental meditation program. Can Med Assoc J 114: pp. 1095-1096
  11. Travis, F, Pearson, C (2000) Pure consciousness: distinct phenomenological and physiological correlates of 鈥渃onsciousness itself鈥? Int J Neurosci 100: pp. 77-89 CrossRef
  12. Alexander, CN, Langer, EJ, Newman, RI, Chandler, HM, Davies, JL (1989) Transcendental meditation, mindfulness, and longevity: an experimental study with the elderly. J Pers Soc Psychol 57: pp. 950-964 CrossRef
  13. Barnes, VA, Orme-Johnson, DW (2012) Prevention and treatment of cardiovascular disease in adolescents and adults through the transcendental meditation ((R)) program: a research review update. Curr Hypertens Rev 8: pp. 227-242 CrossRef
  14. Eppley, KR, Abrams, AI, Shear, J (1989) Differential effects of relaxation techniques on trait anxiety: a meta-analysis. J Clin Psychol 45: pp. 957-974 CrossRef
  15. Paul-Labrador, M, Polk, D, Dwyer, JH, Velasquez, I, Nidich, S, Rainforth, M, Schneider, R, Merz, CN (2006) Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med 166: pp. 1218-1224 CrossRef
  16. Nidich, S, Toomey, M, Myers, H, Rainforth, M, Grandinetti, A, Salerno, J, Gaylord-King, C, Schneider, R (2010) Change in Symptoms of Depression in Minority Subjects at Risk for CVD: Randomized Controlled Mind-Body Intervention Trials. 31st Annual Meeting and Scientific Sessions of the Society of Behavioral Medicine. Rapid Communications. Seattle, WA
  17. Schneider, RH, Alexander, CN, Staggers, F, Orme-Johnson, DW, Rainforth, M, Salerno, JW, Sheppard, W, Castillo-Richmond, A, Barnes, VA, Nidich, SI (2005) A randomized controlled trial of stress reduction in African Americans treated for hypertension for over one year3. Am J Hypertens 18: pp. 88-98 CrossRef
  18. First, MB, Gibbon, M, Spitzer, RL, Williams, JBW (2002) User鈥檚 Guide for the Structured Clinical Interview for DSM-IV-TR Axis I Disorders - Research Version - (SCID-I for DSM-IV-TR). Biometric Research Department, New York State Psychiatric Intitute, New York
  19. Geriatric Mental Health Program 2011.http://www.lhsc.on.ca/Patients_Families_Visitors/MHCP_Adult/Services/Geriatric_Outreach.htm
  20. Hamilton, M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: pp. 56-62 CrossRef
  21. Miller, MD, Paradis, CF, Houck, PR, Mazumdar, S, Stack, JA, Rifai, AH, Mulsant, B, Reynolds, CF (1992) Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 41: pp. 237-248 CrossRef
  22. Washburn, RA, Smith, KW, Jette, AM, Janney, CA (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46: pp. 153-162 CrossRef
  23. Folstein, MF, Folstein, SE, McHugh, PR (1975) 鈥淢ini-mental state鈥? a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: pp. 189-198 CrossRef
  24. Yesavage, JA, Brink, TL, Rose, TL, Lum, O, Huang, V, Adey, M, Leirer, VO (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17: pp. 37-49 CrossRef
  25. Pachana, NA, Byrne, GJ, Siddle, H, Koloski, N, Harley, E, Arnold, E (2007) Development and validation of the Geriatric Anxiety Inventory. Int Psychogeriatr 19: pp. 103-114 CrossRef
  26. Raphael, D, Brown, I, Renwick, R, Cava, M, Weir, N, Heathcote, K (1997) Measuring the quality of life of older persons: a model with implications for community and public health nursing. Int J Nurs Stud 34: pp. 231-239 CrossRef
  27. Vanderkooy, JD, Kennedy, SH, Bagby, RM (2002) Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Can J Psychiatry 47: pp. 174-180
  28. Burke, WJ, Roccaforte, WH, Wengel, SP (1991) The short form of the geriatric depression scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol 4: pp. 173-178 CrossRef
  29. Trijsburg, RW, Van 鈥檛 Spijker, A, van Dam, QD, Duivenvoorden, HJ (1999) De Helping Alliance Questionnaire (HAQ-II). Tijdschr Psychother 25: pp. 56-65 CrossRef
  30. Licht, CM, De Geus, EJ, Van, DR, Penninx, BW (2009) Association between anxiety disorders and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Psychosom Med 71: pp. 508-518 CrossRef
  31. Saghaei, M (2004) Random allocation software for parallel group randomized trials. BMC Med Res Methodol 4: pp. 26 CrossRef
  32. Faul, F, Erdfelder, E, Lang, AG, Buchner, A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39: pp. 175-191 CrossRef
  33. Jasson, S, Medigue, C, Maison-Blanche, P, Montano, N, Meyer, L, Vermeiren, C, Mansier, P, Coumel, P, Malliani, A, Swynghedauw, B (1997) Instant power spectrum analysis of heart rate variability during orthostatic tilt using a time-/frequency-domain method. Circulation 96: pp. 3521-3526 CrossRef
  34. Malliani, A, Lombardi, F, Pagani, M (1994) Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J 71: pp. 1-2 CrossRef
  Heart rate variability for risk stratification of life-threatening arrhythmias. J Am Coll Cardiol 22: pp. 948-950 CrossRef
  35. Calear, AL, Christensen, H (2010) Review of internet-based prevention and treatment programs for anxiety and depression in children and adolescents. Med J Aust 192: pp. S12-S14
  36. Orme-Johnson, D (1987) Medical care utilization and the transcendental meditation program. Psychosom Med 49: pp. 493-507 CrossRef
  37. Herron, RE, Hillis, SL (2000) The impact of the transcendental meditation program on government payments to physicians in Quebec: an update. Am J Health Promot 14: pp. 284-291 CrossRef
  38. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/307/prepub
  
• 刊物主题：Complementary & Alternative Medicine; Internal Medicine; Chiropractic Medicine;
• 出版者：BioMed Central
• ISSN：1472-6882

文摘

Background The prevalence and socioeconomic cost of late life depression (LLD) is on the rise, while the response rate to antidepressant trials remains poor. Various mind-body therapies are being embraced by patients as they are considered safe and potentially effective, yet little is known regarding the effectiveness of such therapies to improve LLD symptoms. Among the mind-body therapies currently in practice, the results of our pilot study have shown that a particular meditation technique called Sahaj Samadhi Meditation, which belongs to the category of meditation termed automatic self-transcending meditation (ASTM) may have some promise in improving cardiovascular autonomic disturbances associated with LLD as well as ameliorating symptoms of depression and anxiety. Methods/Design Patients between the ages of 60 and 85 with LLD will be randomized either to ASTM plus treatment as usual (TAU) or TAU alone to assess changes in cardiovascular autonomic parameters, neuropsychological symptoms of depression and anxiety as well as quality of life. The instructional phase of the intervention consists of 4 consecutive days of meditation training, after which participants are encouraged to meditate twice daily for twenty minutes each time at home. The intervention also includes once weekly follow up sessions for the subsequent 11 weeks. The planned study has one and a half year recruitment period. Participants will be assessed at baseline and at 4, 8, 12 and 24 weeks post intervention. Discussion This study should provide a unique data source from a randomized, controlled, longitudinal trial to investigate the effects of a form of ASTM on cardiovascular autonomic and neuropsychological health in LLD. Trial registration Clinicaltrials.gov NCT02149810, date registered: 05/28/2014.